1. Home
  2. SXT vs LQDA Comparison

SXT vs LQDA Comparison

Compare SXT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

HOLD

Current Price

$132.00

Market Cap

5.5B

Sector

Industrials

ML Signal

HOLD

LQDA

Liquidia Corporation

SELL

Current Price

$42.69

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SXT
LQDA
Founded
1882
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SXT
LQDA
Price
$132.00
$42.69
Analyst Decision
Buy
Buy
Analyst Count
5
8
Target Price
★ $144.40
$54.38
AVG Volume (30 Days)
287.1K
★ 4.8M
Earning Date
10-30-2026
11-06-2026
Dividend Yield
★ 1.25%
N/A
EPS Growth
7.48
★ 51.81
EPS
★ 2.24
1.26
Revenue
★ $1,396,499,000.00
$158,320,000.00
Revenue This Year
$11.85
$357.27
Revenue Next Year
$13.72
$1.34
P/E Ratio
$58.81
★ $31.31
Revenue Growth
N/A
★ 1031.18
52 Week Low
$82.60
$22.05
52 Week High
$138.82
$93.61

Technical Indicators

Market Signals
Indicator
SXT
LQDA
Relative Strength Index (RSI) 51.51 47.91
Support Level $131.37 $35.00
Resistance Level $136.94 $46.67
Average True Range (ATR) 3.23 2.90
MACD 0.01 2.32
Stochastic Oscillator 37.39 99.56

Price Performance

Historical Comparison
SXT
LQDA

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: